N. Patel

发表

Dexamethasone ameliorates renal ischemia-reperfusion injury.

Sanjeev Kumar, D. Allen, J. Kieswich, 2009, Journal of the American Society of Nephrology : JASN.

Urocortin does not reduce the renal injury and dysfunction caused by experimental ischaemia/reperfusion.

N. Patel, C. Thiemermann, M. Collin, 2004, European journal of pharmacology.

Inhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic Shock

N. Patel, C. Thiemermann, K. Brohi, 2015, Molecular medicine.

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders

N. Patel, E. Benetti, F. Chiazza, 2013, Mediators of inflammation.

Artesunate Protects Against the Organ Injury and Hemorrhage and Resuscitation Dysfunction Induced by Severe

M. Barnes, N. Patel, C. Thiemermann, 2016 .

Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation.

M. Barnes, N. Patel, C. Thiemermann, 2017, Annals of surgery.

Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care

N. Patel, C. Thiemermann, K. Nandra, 2012, Critical Care.

Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury.

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, Journal of the American Society of Nephrology : JASN.

Acute Treatment With Bone Marrow–Derived Mononuclear Cells Attenuates the Organ Injury/Dysfunction Induced by Hemorrhagic Shock in the Rat

N. Patel, C. Thiemermann, E. Benetti, 2012, Shock.

IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

J. Kieswich, N. Patel, C. Thiemermann, 2017, Journal of the American Society of Nephrology : JASN.

‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats

N. Patel, C. Thiemermann, R. Sordi, 2015, PloS one.

Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation

M. Barnes, N. Patel, C. Thiemermann, 2017, Annals of surgery.

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, Journal of the American Society of Nephrology : JASN.

Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, Journal of Pharmacology and Experimental Therapeutics.

Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1

N. Patel, K. Rose, A. Ahluwalia, 2017, Scientific Reports.

PPAR Agonism as New Pharmacological Approach to the Management of Acute Ischemic Stroke

N. Patel, E. Benetti, M. Collino, 2012 .

The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion.

N. Patel, C. Thiemermann, M. Yaqoob, 2005, Kidney international.

HIGH-DENSITY LIPOPROTEINS REDUCE THE INTESTINAL DAMAGE ASSOCIATED WITH ISCHEMIA/REPERFUSION AND COLITIS

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Shock.

22 PPAR Agonism as New Pharmacological Approach to the Management of Acute Ischemic Stroke

N. Patel, E. Benetti, M. Collino, 2012 .

Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states

N. Patel, C. Thiemermann, D. Gilroy, 2015, Biology of Sex Differences.

EUK-134 Reduces Renal Dysfunction and Injury Caused by Oxidative and Nitrosative Stress of the Kidney

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, American Journal of Nephrology.

GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*

S. Foster, D. Allen, N. Patel, 2005, Critical care medicine.

Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Free radical research.

Erythropoietin Reduces the Development of Experimental Inflammatory Bowel Disease

N. Patel, E. Mazzon, S. Cuzzocrea, 2004, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis

N. Patel, C. Thiemermann, M. Yaqoob, 2017, Journal of the American Heart Association.

Erythropoietin in the intensive care unit: beyond treatment of anemia

N. Patel, C. Thiemermann, M. Yaqoob, 2011, Annals of intensive care.

Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, Journal of Pharmacology and Experimental Therapeutics.

GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, Kidney international.

Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor

N. Patel, C. Thiemermann, P. Radermacher, 2013, Disease Models & Mechanisms.

Erythropoietin Attenuates Cardiac Dysfunction in Experimental Sepsis via Activation of the β-Common Receptor Running title : EPO reduces septic cardiac dysfunction via the β cR

Christoph, Radermacher, M., 2013 .

Tissue Protective Activities of Erythropoietin

N. Patel, C. Thiemermann, M. Yaqoob, 2010 .

Erythropoietin Preserves the Integrity and Quality of Organs for Transplantation After Cardiac Death

N. Patel, C. Thiemermann, B. Sepodes, 2011, Shock.

TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2002, Free radical biology & medicine.

Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2002, Kidney international.

Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice.

N. Patel, E. Mazzon, S. Cuzzocrea, 2010, Nitric oxide : biology and chemistry.

Junctional Adhesion Molecule–C Mediates Leukocyte Infiltration in Response to Ischemia Reperfusion Injury

P. Meda, N. Patel, C. Thiemermann, 2009, Arteriosclerosis, thrombosis, and vascular biology.

The Effect of β2-Adrenoceptor Agonists on Leucocyte-Endothelial Adhesion in a Rodent Model of Laparotomy and Endotoxemia

N. Patel, C. Thiemermann, R. Pearse, 2020, Frontiers in Immunology.

Programme and Abstracts

N. Patel, C. Thiemermann, S. Bahrami, 2001 .

Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow

N. Patel, C. Thiemermann, R. Pearse, 2013, Critical Care.

The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo.

N. Patel, E. Mazzon, S. Cuzzocrea, 2007, European journal of pharmacology.

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Cardiovascular research.

Peroxisome-proliferator activated receptor- α contributes to the resolution of inflammation following renal ischemia/reperfusion injury

Christoph, N. Patel, E. Mazzon, 2008 .

A Nonerythropoietic Peptide that Mimics the 3D Structure of Erythropoietin Reduces Organ Injury/Dysfunction and Inflammation in Experimental Hemorrhagic Shock

N. Patel, C. Thiemermann, A. Cerami, 2011, Molecular medicine.

Isolation and characterization of polyhydroxyalkanoate and exopolysaccharide producing Bacillus sp. PS1 isolated from sugarcane field in Bhilai, India

N. Patel, P. Shukla, S. Verma, 2011 .

Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice*

N. Patel, E. Mazzon, S. Cuzzocrea, 2006, Critical care medicine.

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Kidney international.

Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor.

J. Kieswich, N. Patel, C. Thiemermann, 2013, Kidney international.

Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury

N. Patel, C. Thiemermann, M. Yaqoob, 2012, Molecular medicine.

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

Michael A. Yamin, N. Patel, C. Thiemermann, 2008, Proceedings of the National Academy of Sciences.

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock

N. Patel, C. Thiemermann, M. Collino, 2012, Disease Models & Mechanisms.

Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Molecular pharmacology.

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

N. Patel, C. Thiemermann, M. Yaqoob, 2010, American journal of respiratory and critical care medicine.

Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase.

N. Patel, E. Mazzon, S. Cuzzocrea, 2007, Journal of the American Society of Nephrology : JASN.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Intensive Care Medicine.

Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, American Journal of Nephrology.

ERYTHROPOIETIN ATTENUATES THE TISSUE INJURY ASSOCIATED WITH HEMORRHAGIC SHOCK AND MYOCARDIAL ISCHEMIA

N. Patel, C. Thiemermann, M. Yaqoob, 2004, Shock.

Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Z. Herceg, N. Patel, S. Cuzzocrea, 2004, The Journal of clinical investigation.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, European journal of pharmacology.

Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, Arthritis and rheumatism.

Neutrophil elastase plays a non‐redundant role in remodeling the venular basement membrane and neutrophil diapedesis post‐ischemia/reperfusion injury

N. Patel, S. Cuzzocrea, C. Thiemermann, 2019, The Journal of pathology.

Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5‐lipoxygenase knockout mice and by the 5‐lipoxygenase inhibitor zileuton

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Journal of leukocyte biology.

Rosiglitazone and 15‐deoxy‐Δ12,14‐prostaglandin J2, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003 .

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, British journal of pharmacology.

Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury

N. Patel, C. Thiemermann, M. Collino, 2008, Therapeutic advances in cardiovascular disease.

Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency

N. Patel, C. Thiemermann, S. Coldewey, 2014, PloS one.

Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction

J. Kieswich, N. Patel, C. Thiemermann, 2008, Laboratory Investigation.

The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat.

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, Kidney international.

INHIBITORS OF NADPH OXIDASE REDUCE THE ORGAN INJURY IN HEMORRHAGIC SHOCK

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, Shock.

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

D. Allen, J. Kieswich, N. Patel, 2004, Journal of the American Society of Nephrology : JASN.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-&ggr;, reduces the development of nonseptic shock induced by zymosan in mice*

N. Patel, S. Cuzzocrea, C. Thiemermann, 2004, Critical care medicine.

Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice

N. Patel, S. Cuzzocrea, C. Thiemermann, 2003, Intensive Care Medicine.

Role of peroxisome proliferator-activated receptor-&ggr; in the protection afforded by 15-deoxy&Dgr;12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin

N. Patel, C. Thiemermann, L. Dugo, 2004, Critical care medicine.

Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states

N. Patel, C. Thiemermann, D. Gilroy, 2015, Biology of Sex Differences.

5-Aminoisoquinolinone reduces colon injury by experimental colitis

N. Patel, E. Mazzon, S. Cuzzocrea, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse

N. Patel, C. Thiemermann, S. Coldewey, 2013, Disease Models & Mechanisms.

Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1

N. Patel, K. Rose, A. Ahluwalia, 2017, Scientific Reports.

Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.

N. Patel, E. Mazzon, S. Cuzzocrea, 2003, Arthritis and rheumatism.

Peroxisome Proliferator-Activated Receptor-α Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury

N. Patel, E. Mazzon, S. Cuzzocrea, 2009, Journal of Pharmacology and Experimental Therapeutics.

Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid.

N. Patel, E. Mazzon, S. Cuzzocrea, 2005, European journal of pharmacology.

The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.

N. Patel, E. Benetti, M. Collino, 2011, Endocrine, metabolic & immune disorders drug targets.

Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study.

N. Patel, C. Thiemermann, M. Perretti, 2009, European journal of pharmacology.

Review of Thermodynamically Evolution of Refrigeration system using Nanoparticles(as a Nanorefrigerant )

Vishwadipsinh J. Ghariya, N. Patel, 2016 .

IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

J. Kieswich, N. Patel, C. Thiemermann, 2017, Journal of the American Society of Nephrology : JASN.

5-Aminoisoquinolinone reduces colon injury by experimental colitis

N. Patel, E. Mazzon, S. Cuzzocrea, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

PPAR Agonism as New Pharmacological Approach to the Management of Acute Ischemic Stroke

N. Patel, E. Benetti, M. Collino, 2012 .

Inhibiting glycogen synthase kinase 3beta in sepsis.

S. Foster, D. Allen, N. Patel, 2007, Novartis Foundation symposium.

Inhibiting Glycogen Synthase Kinase 3β in Sepsis

Eero Mervaala, S. Foster, D. Allen, 2007 .